Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Lightening skin tone is an ancient and well‐documented practice, and remains common practice among many cultures. Whitening agents such as corticosteroids, tretinoin and hydroquinone are medically applied to effectively lighten the skin tone of hyperpigmented lesions. However, when these agents are used cosmetically, they are associated with a variety of side‐effect. Alternative agents, such as arbutin and its derivatives kojic acid and nicotinamide have been subsequently developed for cosmetic purposes. Unfortunately, some cosmetics contain whitening agents that are banned for use in cosmetic products. This article provides an overview of the mode of action and potential side‐effects of cosmetic legal and illegal whitening agents, and the pattern of use of these types of products. Finally, an EU analysis of the health problems due to the presence of illegal products on the market is summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The persistent problem of colorism: skin tone, status, and inequality
Hunter, M. (2007) · Sociology Compass · doi:10.1111/j.1751-9020.2007.00006.x · Cited by 763
Zhu, W., & Gao, J. (2008) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.2008.8 · Cited by 277
Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo
Kameyama, K., Sakai, C., Kondoh, S., Yonemoto, K., Nishiyama, S., Tagawa, M., Murata, T., Ohnuma, T., Quigley, J., Dorsky, A., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90830-0 · Cited by 242
Widespread Use of Toxic Skin Lightening Compounds: Medical and Psychosocial Aspects
Ladizinski, B., Mistry, N., & Kundu, R. V. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2010.08.010 · Cited by 156
Panich, U., Tangsupa-a-nan, V., Onkoksoong, T., Kongtaphan, K., Kasetsinsombat, K., Akarasereenont, P., & Wongkajornsilp, A. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0515-3 · Cited by 127
AlGhamdi, K. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03629.x · Cited by 61
Cited by
Taofiq, O., González-Paramás, A., Barreiro, M., & Ferreira, I. (2017) · Molecules · doi:10.3390/molecules22020281 · Cited by 411
Boo, Y. C. (2019) · Antioxidants · doi:10.3390/antiox8080275 · Cited by 267
Skin whitening cosmetics: feedback and challenges in the development of natural skin lighteners
Burger, P., Landreau, A., Azoulay, S., Michel, T., & Fernandez, X. (2016) · Cosmetics · doi:10.3390/cosmetics3040036 · Cited by 152
Boo, Y. C. (2019) · Antioxidants · doi:10.3390/antiox8090332 · Cited by 119
“However, the satisfaction of consumers is low, and they therefore demand more effective and safer skin lightening ingredients [42,43].”
BackgroundAlnuqaydan, A. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439027 · Cited by 84
Cosmetics in use: A pharmacological review
AK, M. (2019) · Journal of Dermatology & Cosmetology · doi:10.15406/jdc.2019.03.00115 · Cited by 23
Yang, H.-L., Chen, S.-J., Yeh, J.-T., Vadivalagan, C., Chiu, J.-H., Hseu, J.-H., & Hseu, Y.-C. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106206 · Cited by 8
Metadata
- Authors
- Desmedt, B., Courselle, P., De Beer, J. O., Rogiers, V., Grosber, M., Deconinck, E., & De Paepe, K.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2016-03-08
- Volume
- 30
- Issue
- 6
- Pages
- 943-950
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2296690130
- Cited by
- 122
- References
- 6
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.